Understanding how influenza viruses evolve and affect immune responses
NIAID Centers of Excellence for Influenza Research and Response
This study is looking at how bird flu viruses, like H5N1, spread and how our immune system reacts to them, so we can find better ways to protect people from the flu and improve vaccines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11301788 on NIH RePORTER |
What this research studies
This research investigates the factors that influence the evolution and transmission of influenza viruses, particularly focusing on avian strains like H5N1. It involves cohort studies and sampling from both humans and animals to gain insights into how these viruses spread and how the immune system responds to them. By identifying the immune correlates of protection and cross-protection, the research aims to enhance our understanding of effective vaccination strategies against influenza. The findings could lead to improved prevention and treatment methods for influenza infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of influenza infection, particularly those with compromised immune systems or those living in areas with high exposure to avian influenza.
Not a fit: Patients who are not at risk for influenza or those who have already been vaccinated against the specific strains being studied may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and treatments for influenza, potentially reducing the impact of future outbreaks.
How similar studies have performed: Previous research has shown success in understanding influenza virus behavior and immune responses, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Tompkins, S. Mark — University of Georgia
- Study coordinator: Tompkins, S. Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.